glp-1 weight loss drugs tirzepatide semaglutide Researchers move closer to matching patients with drug that works best for them GLP-1s for Weight Loss: What

Preclinical studies have demonstrated the efficacy of short-acting and the more recent long-acting GLP-1 receptor agonists to reduce alcohol self-administration, relapse-like behaviors, and binge drinking in rodent models (Egecioglu et al

Aetna's tirzepatide coverage depends on your specific plan, medical history, and whether your provider documents medical necessitya process that often takes 30 to 60 days

Compared with other peptides with a similar receptor profile, retatrutide is being investigated as a compound with a broader range of activity across metabolic pathways, which is the subject of further research

The 79 study participants who completed one year of treatment had 18% less decline than 87 participants who got a placebo

Cannabis: an overview of its adverse acute and chronic effects and its implications